Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
about
New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel diseaseThe behavior of matrix metalloproteinases and their inhibitors in colorectal cancerRho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation.Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel diseaseModerate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndromePresence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis.The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.Identification of matrix metalloproteinase-2 and -9 activities within intestinal mucosa of clinically healthy beagle dogsIntestinal epithelial cells as producers but not targets of chronic TNF suffice to cause murine Crohn-like pathologyExpression of Blimp-1 in dendritic cells modulates the innate inflammatory response in dextran sodium sulfate-induced colitisPea (Pisum sativum L.) seed albumin extracts show anti-inflammatory effect in the DSS model of mouse colitis.Microarray analysis of anti-cancer effects of docosahexaenoic acid on human colon cancer model in nude miceProtein phosphatase 2A regulates innate immune and proteolytic responses to cigarette smoke exposure in the lung.Preventative oral methylthioadenosine is anti-inflammatory and reduces DSS-induced colitis in mice.Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitisMicrogeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel DiseaseMatrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitisPredominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model.Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.Role of N-acetylcysteine and GSH redox system on total and active MMP-2 in intestinal myofibroblasts of Crohn's disease patients.Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.Transepithelial migration of neutrophils: mechanisms and implications for acute lung injuryInflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets.Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.Increased Expression of Matrix Metalloproteinase-1 and 3 in Remission Patients of Steroid-Dependent Ulcerative Colitis.α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseasesMesh biocompatibility: effects of cellular inflammation and tissue remodelling.Candidate mucosal and surrogate biomarkers of inflammatory bowel disease in the era of new technology.Proteases and the gut barrier.The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases: focus on inflammatory bowel diseases.The role of inflammation and proteinases in tumor progression.Impact of proteolytic enzymes in colorectal cancer development and progression.The significance of matrix metalloproteinases in parasitic infections involving the central nervous system.Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease.Mechanisms of initiation and progression of intestinal fibrosis in IBD.Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel diseaseEffects of ketanserin on experimental colitis in mice and macrophage functionThe molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases.Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
P2860
Q26851490-004110D5-BB97-488A-B4E6-7FB140BC2685Q27004958-98996A7C-AACF-4A5C-8DF3-3E20C419FD59Q27332133-B1F2BF36-F515-4AF4-9525-C59839B02A59Q33387401-CF823355-5384-4755-BA27-354CE93B4983Q33718699-C324DE15-3A7B-4B01-9EF6-7241DEC1453DQ33866294-AB1B421A-3FE4-4869-AFDC-FE2CD78688DEQ33949950-DD9B7517-6000-4DBB-817E-F291C21F02DCQ34136570-A64B4D05-F63A-4FE7-AC40-8510776BC4D8Q34750358-DF0FCC5B-88A6-4532-9D59-6E89DA5CA7A1Q35434989-26B4D265-7E59-4244-8EFE-18765966B004Q35550110-9EFF4359-D3D5-4EDF-8EB0-E989AFFCED4BQ35791892-8C111968-A72D-4541-BE99-2B1A00AC6A32Q35839542-B629644F-600C-4147-A277-C2A7A4B83895Q36114931-472D67A8-8123-4EB6-A90E-9AA30EF40928Q36166985-8E02D029-D402-48EA-8D53-E839D42DE1FBQ36273576-BBA85ADB-AB50-4E11-9310-64F46979AD6DQ36382078-96DDAC0D-FB7F-4279-A405-866AB211F59BQ36826903-9F9D0E28-1917-4757-827F-437FA761C5EAQ36897929-393BB21C-5142-4602-94E2-F8906FFBD319Q37015254-E0B141DA-066F-4EBC-A053-92D1E8487E31Q37100247-885406B2-58FF-49ED-9AF6-1F66B8621A1AQ37180272-9F160ED8-3859-40E5-AAC3-EF39DBF64FA7Q37258771-5271F9BF-3158-4322-A36D-3C9A7E4B3D7FQ37384864-6975F413-3B90-44D9-868F-FD65285199EFQ37477606-78F228B9-B0C4-440E-8AD8-8523535C599AQ37624490-6A691B8D-8C26-449A-ADFB-D5737760B47AQ37706103-BB8B472D-3B80-45FC-9E0E-FF6B46268477Q37860197-32E0EE0C-4A69-4E86-BB81-DBDB2021562FQ37951110-487B2C2E-3572-4BA8-A1F0-DCBB2CC4014CQ37994635-869E105C-9CC3-4DBA-8571-D164AD7192F7Q38016615-B1283A34-9354-4400-ADFD-152DA5298966Q38020728-5AFD9074-F764-408F-BFAA-7102972FA152Q38259533-60E3D72B-A48A-402A-A078-C54EE9B22FD2Q38273202-BF3F93E7-D293-44B9-A1CE-96D9D8ABAA12Q38293774-9C66A523-21F8-4BE1-BA19-BE673754BA85Q38293779-85208E0B-B2CC-4175-9CFD-B9F774B40BCEQ38660544-8DAD3F16-EA45-4C0C-B9A9-5B46E8B7A9C6Q38677662-AF9CBE16-6BDF-4D87-83F0-24308485A4F5Q38881849-7917E4B5-3261-4901-9C2F-CC2B363C48D0Q38976561-8932A1CD-6A6E-465C-85F6-36EFE3B069AC
P2860
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
@ast
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
@en
type
label
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
@ast
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
@en
prefLabel
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
@ast
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
@en
P2093
P2860
P356
P1476
Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?
@en
P2093
Anupama Ravi
Pallavi Garg
Shanthi V Sitaraman
P2860
P304
P356
10.1002/IBD.20011
P577
2007-01-01T00:00:00Z